Abstract Submission Instructions

SVIN 2024 Abstract Submission is now closed.

Late Breaking and Clinical Trial Abstracts

During the submission process, you will select one primary category that your abstract falls within: Late Breaking Science or Clinical Trials.
Late Breaking Science: This category is intended for abstracts that significantly influence the future of interventional and stroke care and treatment. They must highlight exceptionally important results obtained after the September 6th abstract submission deadline.
Clinical Trials: This category is intended for abstracts detailing the rationale and design of clinical trials, as well as updates on eligibility and recruitment for ongoing or recently completed clinical trials or large multicenter registries.
Late Breaking and Clinical Trial abstracts will be considered for platform presentation by default.
Any abstract that does not fit the above criteria should not be submitted as a Late Breaking or Clinical Trial abstract and will not be considered for inclusion in the SVIN 2024 program.

Important Information

All accepted abstracts will be included on the SVIN website, mobile app and S:VIN Journal.
The abstract maximum length is 500 words NOT including Title, Authors, Affiliations, and Disclosures. Each graphic or table is considered 100 words with maximum two graphics or tables per abstract.
The presenting author must be an author of the abstract.
Presenting authors of accepted abstracts will be required to register for and attend the SVIN 2024 Annual Meeting. Registration fees are required and are not waived with acceptance.
Authors have the option to submit their abstract for one of the three following options:
- E-Poster Presentation Only
- Platform Presentation Only
- Platform or E-Poster Presentation
If ‘Platform Presentation Only’ is selected, consideration will not be made for a poster presentation. Similarly, if ‘E-Poster Presentation Only’ is selected, consideration will not be made for a platform presentation.
IMPORTANT! SVIN will accept only one platform presentation per presenting author. If one submits more than one abstract for platform presentation, the others will automatically be reviewed for E-poster presentation if the author chooses ‘Platform or E-Poster’ during the abstract submission process - not platform.
There is a maximum of one platform and two E-poster presentations per presenting author.
Avoid trade names when possible. You may use the trade name once, for example - ticagrelor (Brilinta).
All authors that had influence over the content of the abstract must disclose. When submitting the abstract online, please list the names of the authors and the corresponding financial disclosures.
Please ensure that all authors have been submitted with your abstract as you will not be able to add additional authors after the review period begins.
Authors are strongly encouraged to submitting their manuscript to Stroke: Vascular and Interventional Neurology for publication.
Abstract notification will be sent via email in September 2024 following peer review. Late Breaking abstract notification will be sent via email in October 2024 following peer review.

Preparation of Your Abstract

No identifying features such as names of hospitals, medical schools, or cities may be listed in the title or text of the abstract. Do NOT include the names of any of the authors. The names of authors and their affiliations (institutions) will be submitted on-line during the process.
Abstracts previously presented at a national/international meeting may be submitted to SVIN. Please cite the meeting, location, and date of previous presentation. Abstracts CANNOT be previously published in a manuscript.
The title cannot be longer than 15 words but should clearly indicate the nature of the study. Capitalize the first letter of each word within the title.
Abstracts should state clearly and briefly the purpose, methods, results and conclusions of the work. There is a strict 500-word limit for the abstract body; each graphic or table counts as 100 words. Please format abstracts using the following headings:
- Introduction/Purpose: Clearly state the purpose of the study.
- Materials/Methods: Describe the design of the study clearly.
- Results: Present your results in a logical sequence.
- Conclusion: Emphasize new and important aspects of the study and conclusions that are drawn from your results.

The Submission Process

To submit an abstract, please visit our online Abstract Submission site and register with the system. All users will need to create an account by clicking on “Create New Account”. Complete the form with the required fields. Once that form is submitted, you will be redirected to the login page. Please be sure to save these login credentials.
Log into the system using the username and password you chose. To begin a new submission, select “Submissions” and then “Add New”.
Submitting an abstract is a multi-step process. To submit a new abstract, log into the system and click on “Add New”. This will take you through the steps of submitting your abstracts. Be sure to read the directions on each page carefully. There are multiple steps within the abstract submission process:
Step 1: Title
Step 2: Category
Step 3: Presentation Preference
Step 4: Keyword(s)
Step 5: Author(s)
Step 6: Abstract Body
Step 7: Additional Information
Step 8: Award Consideration
Step 9 (if applicable): Travel Grant Files
Step 10: Review and Submit
You will select one primary category that your abstract falls within. The categories to choose from are as follows:
- Aneurysm/Vascular Malformations
- Basic Science
- Education
- Emerging Technology
- Extracranial Interventions
- Global Health/Health Equity
- Imaging
- Intracranial/Subarachnoid Hemorrhage
- Intracranial Stenosis
- Ischemic Stroke – Vascular Neurology
- Ischemic Stroke – Neurointervention
- Large Artery Disease
- Neurocritical Care
- Other Pathology
- Stroke Systems of Care
- Venous Disease and Interventions
Questions marked with a red asterisk* are required fields. The system will indicate which of the steps you have not completed when you go to finalize and submit your abstract. You can also save and continue your abstract at a later time, but please ensure it is submitted by the deadline.
For each abstract submitted, a maximum of two graphic files or tables is permitted. Ensure file resolution is ≥300 dpi. Please upload file(s) as jpg or gif formats only.
Once an abstract has been submitted, additional edits can be made until the abstract deadline. If you wish to delete a submission, you can do so within the ‘Submissions’ window and selecting “Delete” within each listed abstract submission.
To submit additional abstracts, select ‘Home’ button in the upper right-hand corner of the screen to return to the ‘Submissions’ window and then select “Add New.” You will need to close out of the current abstract (including reviewing an already submitted abstract) before beginning a new submission.

SVIN Abstract Withdrawal Policy

It is SVIN’s expectation that all accepted abstracts will, under all usual circumstances, be presented at the meeting. If the presenting author is unable to present an abstract, a co-author is eligible to present on their behalf. Failure to present an accepted abstract may cause the author(s) to be ineligible for abstract submission at next year’s annual meeting.

To request withdraw of an abstract prior to the submission deadline, please withdraw directly in the system. Following the submission deadline, all withdrawal requests must be requested in writing to the SVIN Speaker Team at education@svin.org. The final date to request a withdrawal will be October 7, 2024.

Contact Info

Reach out if you have any questions or concerns with the abstract submission platform:
Email: SVIN@support.ctimeetingtech.com
Phone: 217-398-1792

Standard support hours are Monday thru Friday, 8:00 am to 5:00 pm US Central.

Abstract Awards

Best Scientific Abstract Award: One award will be given at the SVIN Annual Meeting for the outstanding scientific abstract submitted by a member of the society.

Young Investigator Award: One award will be given at the SVIN Annual Meeting for the outstanding abstract submitted by a student, resident, fellow or early career attending (five years or less out of fellowship).

The presenting author must be a current member of SVIN at the time the abstract is submitted.
The presenting author must be a medical student, resident, fellow, or early career attending (five years or less out of fellowship) at the time of submission to qualify for the award.
The recipient is required to attend the annual meeting.
Only abstracts that are designated for consideration of the Young Investigator Award by the author during the submission process will be considered.
The Abstract Review Committee will decide on the award.

Trainee Travel Grant: Multiple awards will be given to support the efforts of trainees in cerebrovascular research and encourage participation at the SVIN Annual Meeting. These awards will provide travel funds for junior investigators to attend the meeting, present their research in oral or poster format, and engage in discussion with senior investigators.

The presenting author must be a current member of SVIN at the time of application.
The presenting author must be a medical student, resident or fellow at the time of submission to qualify for the award. Priority will be given to fellow-in-training applicants.
The recipient is required to attend the annual meeting.
Only abstracts that are designated for consideration of the Trainee Travel Grant by the author during the submission process will be considered.
Applicants must submit an abstract and upload the required supporting materials prior to the deadline. Only complete applications will be considered.
The Abstract Review Committee will decide on the awards.